CRISPR Therapeutics AG (CRSP)
33.14
-0.89
(-2.62%)
USD |
NASDAQ |
Apr 01, 16:00
32.88
-0.26
(-0.78%)
After-Hours: 07:12
CRISPR Therapeutics Total Liabilities (Quarterly): 309.95M for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 6.124B |
| AC Immune SA | 131.31M |
| Addex Therapeutics Ltd | 1.315M |
| NLS Pharmaceutics Ltd | 10.46M |
| Molecular Partners AG | 18.69M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.242B |
| Shareholders Equity (Quarterly) | 1.932B |
| Current Ratio | 22.07 |